Societe Generale analyst Justin Smith upgraded Roche to Buy from Hold.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on RHHBY:
- Blueprint Medicines to regain global rights to gavreto from Roche
- Roche launch two new antibodies to identify mutations in brain cancer patients
- Roche launches two new antibodies to identify key clinical mutations in patients with brain cancer
- iBio downgraded to Market Perform at JMP on CDMO and IBIO-101 questions
- Hookipa Pharma achieves $10M milestone payment under Roche collaboration